ANTIBODY-DRUG CONJUGATES MARKET OVERVIEW: SIZE, TARGET POPULATION, COMPETITIVE LANDSCAPE, AND LONG-TERM GROWTH PROSPECTS

Antibody-drug conjugates are an innovative development in cancer therapy, combining monoclonal antibodies with potent cytotoxic agents to deliver precise and targeted treatments. This method improves therapeutic efficacy while minimizing the risk of systemic toxicity, positioning antibody-drug conjugates as a pivotal breakthrough in oncology. With